FGF19 and hepatocellular carcinoma: Moreover, we identify fibroblast growth factor 19 (FGF19), a soluble growth factor recently involved in hepatocarcinogenesis and a β-catenin pathway activator [32], [33], as a novel agonist for AR gene expression in human HCC cells.